about
Renal lithiasis and nutrition.Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study.Effect of consuming a grape seed supplement with abundant phenolic compounds on the oxidative status of healthy human volunteersPhytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis.Effects of polyphenols from grape seeds on renal lithiasis.A new device for simple and accurate urinary pH testing by the Stone-former patient.Internalization of Calcium Oxalate Calculi Developed in Narrow Cavities.Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.A potential role for crystallization inhibitors in treatment of Alzheimer's disease.Effects of exogenous inositol hexakisphosphate (InsP(6)) on the levels of InsP(6) and of inositol trisphosphate (InsP(3)) in malignant cells, tissues and biological fluids.Study of potassium phytate effects on decreasing urinary calcium in rats.Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.Effect of phytate on element bioavailability in the second generation of rats.Urinary lithogenesis risk tests: comparison of a commercial kit and a laboratory prototype test.Phytotherapy and renal stones: the role of antioxidants. A pilot study in Wistar rats.Anticalculus effect of a triclosan mouthwash containing phytate: a double-blind, randomized, three-period crossover trial.Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis.Study of the absorption of myo-inositol hexakisphosphate (InsP6) through the skin.Phytate reduces age-related cardiovascular calcification.Phytate inhibits bovine pericardium calcification in vitro.Characterization of deposits in patients with calcific tendinopathy of the supraspinatus. Role of phytate and osteopontin.Variation of InsP(4),InsP(5) and InsP(6) levels in tissues and biological fluids depending on dietary phytate.Influence of concomitant food intake on the excretion of orally administered myo-inositol hexaphosphate in humans.Effect of Consumption of Cocoa-Derived Products on Uric Acid Crystallization in Urine of Healthy VolunteersDietary effects upon calcium oxalate urolithiasis riskAn animal model to study the effects of diet on risk factors of calcium stone formationMorphological adaptive changes of small intestinal tract regions due to pregnancy and lactation in ratsUrolithiasis and phytotherapyInositol hexakisphosphate in urine: the relationship between oral intake and urinary excretionUrinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretionEffect of atrial natriuretic peptide on alpha-methyl-D-glucoside intestinal active uptake in ratsEffect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley ratsEffects of short and long-term indapamide treatments on urinary calcium excretion in patients with calcium oxalate dihydrate urinary stone disease: a pilot studyRare calcium oxalate monohydrate calculus attached to the wall of the renal pelvisA simple and rapid colorimetric method for determination of phytate in urineUrinary pH and renal lithiasisPhytotherapy in a rat model of hyperoxaluria: the antioxidant effects of quercetin involve serum paraoxonase 1 activation[Rare kidney stones]
P50
Q35062389-D6EBF979-8C6A-4FEB-89DC-D23506C56DB0Q35760476-FA8408D6-DD51-481F-83F3-C9CF149DA693Q36040894-43D52975-4E9D-4CF1-9D2E-471811A5D77FQ37602052-0DA9B9EF-DDE9-42F0-AE9F-998880B92122Q39398539-04959FFB-4E1C-4D97-8008-6B591091BD09Q39664489-42BB8440-3754-4DDD-89BF-E386D861A871Q42536813-9AF22F4D-E813-40EC-8E03-280E2A5D0401Q43182268-2D6929A7-1967-4BF3-AC09-C7BB8496AF0CQ43295390-EDF3F75A-2549-4F16-BBBF-8B115A72C9CBQ44071552-9E33BEBF-88F2-42BA-A5B9-DD21A8D92BE4Q44845034-41E5E4E3-194E-4278-83EE-75CBEC850E7FQ44854596-1283BA39-FFE3-46B3-877B-2AC3CAEC76BCQ44893368-EC10F760-C0F9-4864-8862-4EAAD171F807Q45351730-5858735B-B6C9-46FE-ABF5-1D5C4ECE3341Q46208259-C810BF50-7606-4F5F-AE41-EC2D34BC9021Q46273392-A8BBCDE0-33DC-47D9-987B-023EB0328DC7Q46283183-BEC47935-9CCC-48CE-87B5-E384D172893CQ46283784-86EF2C0D-3CCC-48D0-AA5C-107D3A4BC331Q46415110-B3C63604-99C8-4832-A80D-37C3C11BE19FQ46570780-8FA2DEC4-FC1F-4AF5-BD1E-947C2B8C3C48Q46652259-9F0734F8-756B-4379-9AB1-143A50D66CD0Q47776076-D2205FAF-BD29-41C3-A777-92F8C6995219Q48595743-45436EC7-DB6D-40B3-A257-30C5CC53DD25Q51500747-AFF5A18E-CAF3-4B83-8229-1EB435071292Q58558169-C3F4BEB3-7A69-4A0F-AC7B-819F88F70A0EQ67507752-B316A80A-5B90-47E7-920F-BF18D11920A1Q67837726-77000345-7DF9-4312-BC4F-318D08BE224FQ72141427-5E911884-B97B-47B8-B207-0D844258D4E1Q72555464-518CD4F4-F09A-4802-B268-1D1D26DCA79EQ73321680-27CED453-6286-4B86-AB8F-3EC04F7111D4Q74231150-553ACB36-C985-4116-9A88-7DE84D0280FFQ77456401-321B5608-7CCD-457F-9CF9-CD6AD55C2A91Q80517836-4A0E63DF-A5F2-446B-950C-99E6D43F49A3Q83259169-84861C7E-BE79-4C27-BD7A-B70C11BCB9A9Q83486083-72FC9CDE-CA18-4CA7-82FC-AB339DC420CBQ83811383-B6B334FB-85C9-4905-8099-B66B6A8644D4Q84145584-5C15B161-0967-45F5-AA71-44B2C3509761Q84892909-B1088F44-A202-454A-B48B-82B53FE31C1FQ85007457-F767DEB4-D4AA-4683-8E54-F96B37BB2BB3
P50
description
Spaans onderzoeker
@nl
hulumtues
@sq
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Rafael M. Prieto Almirall
@es
Rafael M. Prieto
@ast
Rafael M. Prieto
@en
Rafael M. Prieto
@ga
Rafael M. Prieto
@nl
Rafael M. Prieto
@sl
Rafael M. Prieto
@sq
Rafael Maria Prieto Almirall
@ca
type
label
Rafael M. Prieto Almirall
@es
Rafael M. Prieto
@ast
Rafael M. Prieto
@en
Rafael M. Prieto
@ga
Rafael M. Prieto
@nl
Rafael M. Prieto
@sl
Rafael M. Prieto
@sq
Rafael Maria Prieto Almirall
@ca
altLabel
Rafael M. Prieto
@en
Rafael Maria Prieto Almirall
@es
Rafael Prieto Almirall
@es
Rafael Prieto
@en
Rafel Prieto
@en
prefLabel
Rafael M. Prieto Almirall
@es
Rafael M. Prieto
@ast
Rafael M. Prieto
@en
Rafael M. Prieto
@ga
Rafael M. Prieto
@nl
Rafael M. Prieto
@sl
Rafael M. Prieto
@sq
Rafael Maria Prieto Almirall
@ca
P1053
J-3995-2017
P106
P1153
35512642200
P1477
Rafael María Prieto Almirall
@es
P21
P27
P2798
P31
P3829
P496
0000-0001-8814-900X